A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability of teclistamab when
administered in different combination regimen and to identify the optimal dose(s) of
teclistamab combination regimens.